Market Overview:
The global total artificial heart market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in the field of artificial hearts, and rising demand for minimally invasive surgeries. The global total artificial heart market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into SynCardia and others. On the basis of application, the market is segmented into dilated cardiomyopathy (DCM), ischemic cardiomyopathy (ICM), and others. The North America region dominates this market followed by Europe due to early adoption rates for new technologies in these regions coupled with increasing incidence rates for cardiovascular diseases.
Product Definition:
A Total Artificial Heart is a device used to replace the function of a failing heart. The importance of a Total Artificial Heart is that it can provide temporary support for patients who are awaiting a heart transplant.
SynCardia:
SynCardia is a Synchronized Cardiac Rhythm Management Device (SCRAM) used in patients suffering from heart failure and bradycardia. It works by synchronizing the patient’s own heartbeat with that of the external pacemaker. The device was approved by the U.S Food and Drug Administration (FDA) for emergency use in December 2012, following its approval by European regulatory bodies two months prior.
Others:
Others are the accessories that are used in total artificial heart market. It includes devices such as implantable cardioverter defibrillators, pacemakers, and catheters. The others segment is expected to grow at a lucrative CAGR during the forecast period owing to increasing prevalence of cardiovascular diseases (CVDs) and growing demand for minimally invasive surgeries.
Application Insights:
The others segment held the largest share of more than 50.0% in 2017. This is due to the increasing incidence of heart diseases, which are incurable with current medical technology. The global total artificial heart market is expected to witness significant growth owing to rising demand for these devices from countries, such as India and China, where cardiovascular diseases are highly prevalent. According to WHO data published in 2018, around 1 in every 3 deaths occur due to Cardiovascular Diseases (CVDs) globally and this number is expected to increase by around 70 million by 2030 if urgent preventive measures are not taken now. Thus, there will be a huge potential demand for total artificial hearts over the forecast period from various regions globally as a result of growing prevalence of CVDs coupled with rising awareness about these devices among patients across the globe.
Dilated cardiomyopathy application segment accounted for one-fourthth share in 2017 owingto its high adoption ratein U.S.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement policies. The U.S holds a major share in North America artificial heart market due to factors such as increasing geriatric population and prevalence of cardiac diseases that result in higher mortality rates among Americans than any other country.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure and rising patient awareness about artificial heart implantsation procedure availability across this region.
Growth Factors:
- Increasing prevalence of heart failure: The total artificial heart market is expected to grow at a CAGR of 9.5% from 2016 to 2021, owing to the increasing prevalence of heart failure. According to the American Heart Association, around 5 million people in the U.S. are affected by heart failure and this number is expected to increase due to the aging population and rising incidence of lifestyle diseases such as obesity and diabetes mellitus
- Technological advancements: The total artificial heart market is witnessing significant technological advancements with companies launching new products with enhanced features such as smaller size, longer life span, and low power consumption. This is likely to boost the growth of the market during the forecast period
- Rising demand for minimally invasive procedures: Minimally invasive procedures are gaining popularity due their benefits over traditional open-heart surgeries such as shorter hospital stay, reduced pain & blood loss, and faster recovery time. This is anticipated to drive demand for total artificial hearts during the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Total Artificial Heart Market Research Report
By Type
SynCardia, Others
By Application
Dilated Cardiomyopathy, Ischemic Cardiomyopathy, Others
By Companies
BiVACOR, SynCardia, Jarvik Heart, CARMAT, AbioMed
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Total Artificial Heart Market Report Segments:
The global Total Artificial Heart market is segmented on the basis of:
Types
SynCardia, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dilated Cardiomyopathy, Ischemic Cardiomyopathy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BiVACOR
- SynCardia
- Jarvik Heart
- CARMAT
- AbioMed
Highlights of The Total Artificial Heart Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- SynCardia
- Others
- By Application:
- Dilated Cardiomyopathy
- Ischemic Cardiomyopathy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Total Artificial Heart Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Total Artificial Heart is a heart replacement device that helps people with heart failure live longer.
Some of the key players operating in the total artificial heart market are BiVACOR, SynCardia, Jarvik Heart, CARMAT, AbioMed.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Total Artificial Heart Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Total Artificial Heart Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Total Artificial Heart Market - Supply Chain
4.5. Global Total Artificial Heart Market Forecast
4.5.1. Total Artificial Heart Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Total Artificial Heart Market Size (000 Units) and Y-o-Y Growth
4.5.3. Total Artificial Heart Market Absolute $ Opportunity
5. Global Total Artificial Heart Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Total Artificial Heart Market Size and Volume Forecast by Type
5.3.1. SynCardia
5.3.2. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Total Artificial Heart Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Total Artificial Heart Market Size and Volume Forecast by Application
6.3.1. Dilated Cardiomyopathy
6.3.2. Ischemic Cardiomyopathy
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Total Artificial Heart Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Total Artificial Heart Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Total Artificial Heart Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Total Artificial Heart Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Total Artificial Heart Demand Share Forecast, 2019-2026
9. North America Total Artificial Heart Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Total Artificial Heart Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Total Artificial Heart Market Size and Volume Forecast by Application
9.4.1. Dilated Cardiomyopathy
9.4.2. Ischemic Cardiomyopathy
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Total Artificial Heart Market Size and Volume Forecast by Type
9.7.1. SynCardia
9.7.2. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Total Artificial Heart Demand Share Forecast, 2019-2026
10. Latin America Total Artificial Heart Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Total Artificial Heart Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Total Artificial Heart Market Size and Volume Forecast by Application
10.4.1. Dilated Cardiomyopathy
10.4.2. Ischemic Cardiomyopathy
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Total Artificial Heart Market Size and Volume Forecast by Type
10.7.1. SynCardia
10.7.2. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Total Artificial Heart Demand Share Forecast, 2019-2026
11. Europe Total Artificial Heart Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Total Artificial Heart Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Total Artificial Heart Market Size and Volume Forecast by Application
11.4.1. Dilated Cardiomyopathy
11.4.2. Ischemic Cardiomyopathy
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Total Artificial Heart Market Size and Volume Forecast by Type
11.7.1. SynCardia
11.7.2. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y rowth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Total Artificial Heart Demand Share, 2019-2026
12. Asia Pacific Total Artificial Heart Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Total Artificial Heart Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Total Artificial Heart Market Size and Volume Forecast by Application
12.4.1. Dilated Cardiomyopathy
12.4.2. Ischemic Cardiomyopathy
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Total Artificial Heart Market Size and Volume Forecast by Type
12.7.1. SynCardia
12.7.2. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Total Artificial Heart Demand Share, 2019-2026
13. Middle East & Africa Total Artificial Heart Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Total Artificial Heart Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Total Artificial Heart Market Size and Volume Forecast by Application
13.4.1. Dilated Cardiomyopathy
13.4.2. Ischemic Cardiomyopathy
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Total Artificial Heart Market Size and Volume Forecast by Type
13.7.1. SynCardia
13.7.2. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Total Artificial Heart Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Total Artificial Heart Market: Market Share Analysis
14.2. Total Artificial Heart Distributors and Customers
14.3. Total Artificial Heart Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BiVACOR
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. SynCardia
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Jarvik Heart
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. CARMAT
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AbioMed
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
